FDA Inspection 1269021 — Shanghai Wonder Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shanghai Wonder Pharmaceutical Co., Ltd. on March 14, 2025 in Shanghai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 14, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shanghai (China)